EVGN (Evogene) Ending Cash Position : $15.30 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Evogene Ending Cash Position?

Evogene's Ending Cash Position for the quarter that ended in Dec. 2024 was $15.30 Mil.

Evogene's quarterly Ending Cash Position increased from Jun. 2024 ($9.48 Mil) to Sep. 2024 ($11.32 Mil) and increased from Sep. 2024 ($11.32 Mil) to Dec. 2024 ($15.30 Mil).

Evogene's annual Ending Cash Position declined from Dec. 2022 ($28.98 Mil) to Dec. 2023 ($20.77 Mil) and declined from Dec. 2023 ($20.77 Mil) to Dec. 2024 ($15.30 Mil).

Evogene Ending Cash Position Historical Data

The historical data trend for Evogene's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evogene Ending Cash Position Chart

Evogene Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

46.23

32.33

28.98

20.77

15.30

Evogene Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															20.77	11.92	9.48	11.32	15.30

Evogene Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Evogene's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	20.772	+	-5.471
	=	15.30

Evogene's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11.317	+	3.984
	=	15.30

Evogene Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Evogene's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Evogene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evogene Ltd (NAS:EVGN) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

EVGN:Israel

Address

13 Gad Feinstein Street, Park Rehovot, Ness Ziona, Rehovot, ISR, 7638517

Website

https://www.evogene.com

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.